Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens-Reference-Cited by-同舟云学术

Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens

Published:2009-08 Issue:4 Volume:9 Page:307-310
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Kelly Jennifer L.,Toothaker Stephen R.,Ciminello Lauren,Hoelzer Dieter,Holte Harald,LaCasce Ann S.,Mead Graham,Thomas Deborah,Van Imhoff Gustaaf W.,Kahl Brad S.,Cheson Bruce D.,Magrath Ian T.,Fisher Richard I.,Friedberg Jonathan W.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference26 articles.

1. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90;Reiter;Blood,1999

2. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents;Cairo;Blood,2007

3. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients;Patte;Blood,2007

4. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen;Magrath;J Clin Oncol,1996

5. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia;Kantarjian;J Clin Oncol,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Andrographolide inhibits Burkitt’s lymphoma by binding JUN and CASP3 proteins;Cancer Chemotherapy and Pharmacology;2023-12-26

2. R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial;The Lancet Haematology;2023-12

3. Primary Burkitt lymphoma of the cecal appendix: Case report;REV CUERPO MED HOSP;2023

4. Blinatumomab in Relapsed/Refractory Burkitt Lymphoma;Cancers;2022-12-21

5. Burkitt lymphoma;Nature Reviews Disease Primers;2022-12-15